Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Merkel Cell | 31 | 2024 | 329 | 10.310 |
Why?
|
Polyomavirus Infections | 18 | 2023 | 192 | 6.690 |
Why?
|
Tumor Virus Infections | 18 | 2023 | 437 | 5.570 |
Why?
|
Antigens, Polyomavirus Transforming | 33 | 2022 | 256 | 4.320 |
Why?
|
Simian virus 40 | 24 | 2022 | 292 | 3.890 |
Why?
|
Antigens, Viral, Tumor | 15 | 2022 | 153 | 3.360 |
Why?
|
Retinoblastoma Protein | 40 | 2019 | 671 | 3.000 |
Why?
|
Cell Cycle Proteins | 38 | 2022 | 3443 | 2.920 |
Why?
|
Skin Neoplasms | 26 | 2024 | 5861 | 2.850 |
Why?
|
Cell Cycle | 42 | 2024 | 2932 | 2.240 |
Why?
|
Polyomavirus | 9 | 2022 | 235 | 1.980 |
Why?
|
Cell Transformation, Viral | 11 | 2020 | 530 | 1.820 |
Why?
|
Kv Channel-Interacting Proteins | 7 | 2021 | 39 | 1.610 |
Why?
|
Tumor Suppressor Protein p53 | 21 | 2022 | 2953 | 1.600 |
Why?
|
Retinoblastoma-Like Protein p130 | 14 | 2019 | 72 | 1.530 |
Why?
|
Cullin Proteins | 9 | 2018 | 180 | 1.410 |
Why?
|
Mitosis | 9 | 2022 | 1177 | 1.320 |
Why?
|
Immunoprecipitation | 3 | 2020 | 874 | 1.290 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 4 | 2022 | 361 | 1.230 |
Why?
|
Repressor Proteins | 12 | 2022 | 2982 | 1.210 |
Why?
|
Proteins | 16 | 2020 | 6009 | 1.150 |
Why?
|
Trans-Activators | 13 | 2021 | 2857 | 1.110 |
Why?
|
Nuclear Proteins | 30 | 2020 | 5799 | 1.040 |
Why?
|
DNA, Viral | 7 | 2020 | 2201 | 1.040 |
Why?
|
Antigens | 4 | 2020 | 1442 | 1.030 |
Why?
|
Phosphoproteins | 20 | 2020 | 2450 | 1.030 |
Why?
|
Carrier Proteins | 21 | 2012 | 4937 | 0.870 |
Why?
|
Cell Transformation, Neoplastic | 14 | 2022 | 2846 | 0.820 |
Why?
|
Retinoblastoma-Like Protein p107 | 7 | 2019 | 70 | 0.790 |
Why?
|
Ubiquitin-Protein Ligases | 11 | 2021 | 1901 | 0.780 |
Why?
|
DNA Helicases | 6 | 2018 | 854 | 0.770 |
Why?
|
DNA-Binding Proteins | 29 | 2018 | 9614 | 0.740 |
Why?
|
BK Virus | 1 | 2022 | 120 | 0.740 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2021 | 8637 | 0.710 |
Why?
|
Transcription Factors | 34 | 2021 | 12165 | 0.700 |
Why?
|
F-Box Proteins | 3 | 2012 | 199 | 0.700 |
Why?
|
Host-Pathogen Interactions | 5 | 2017 | 1469 | 0.680 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2020 | 124 | 0.680 |
Why?
|
Cyclin D | 2 | 2019 | 71 | 0.670 |
Why?
|
Protein Denaturation | 1 | 2020 | 242 | 0.670 |
Why?
|
Tumor Suppressor Proteins | 11 | 2014 | 2800 | 0.660 |
Why?
|
Detergents | 1 | 2020 | 235 | 0.650 |
Why?
|
5' Untranslated Regions | 1 | 2020 | 255 | 0.650 |
Why?
|
Phosphorus Radioisotopes | 1 | 2018 | 100 | 0.630 |
Why?
|
Antigen-Antibody Complex | 1 | 2020 | 513 | 0.630 |
Why?
|
Pyrazines | 2 | 2021 | 1205 | 0.600 |
Why?
|
Open Reading Frames | 2 | 2020 | 818 | 0.590 |
Why?
|
Protein Binding | 35 | 2020 | 9343 | 0.570 |
Why?
|
E2F4 Transcription Factor | 6 | 2014 | 33 | 0.570 |
Why?
|
Cell Line | 35 | 2023 | 15597 | 0.570 |
Why?
|
Host Specificity | 2 | 2018 | 56 | 0.560 |
Why?
|
Cyclin-Dependent Kinase 4 | 7 | 2019 | 564 | 0.550 |
Why?
|
Gene Expression Regulation | 19 | 2021 | 11930 | 0.540 |
Why?
|
Schizosaccharomyces pombe Proteins | 4 | 2013 | 177 | 0.520 |
Why?
|
Cyclins | 11 | 2016 | 605 | 0.520 |
Why?
|
Multiprotein Complexes | 7 | 2021 | 1110 | 0.510 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 9 | 2020 | 1731 | 0.510 |
Why?
|
Blotting, Western | 15 | 2020 | 5024 | 0.510 |
Why?
|
Forkhead Transcription Factors | 3 | 2013 | 1625 | 0.500 |
Why?
|
Genome, Viral | 3 | 2021 | 674 | 0.500 |
Why?
|
Phosphorylation | 37 | 2021 | 8314 | 0.490 |
Why?
|
Protein Kinase Inhibitors | 7 | 2021 | 5694 | 0.490 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2017 | 998 | 0.480 |
Why?
|
Anilides | 1 | 2018 | 413 | 0.480 |
Why?
|
Phosphates | 1 | 2018 | 765 | 0.470 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2015 | 209 | 0.470 |
Why?
|
Ubiquitination | 5 | 2018 | 1008 | 0.460 |
Why?
|
S Phase | 8 | 2022 | 424 | 0.460 |
Why?
|
Pyrazoles | 3 | 2021 | 2028 | 0.450 |
Why?
|
Cell Proliferation | 12 | 2022 | 10470 | 0.450 |
Why?
|
Organogenesis | 1 | 2015 | 214 | 0.440 |
Why?
|
DNA Replication | 12 | 2022 | 1427 | 0.440 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2013 | 110 | 0.440 |
Why?
|
RNA, Viral | 2 | 2020 | 2871 | 0.430 |
Why?
|
Hot Temperature | 1 | 2020 | 1441 | 0.430 |
Why?
|
Antibodies | 2 | 2020 | 2421 | 0.410 |
Why?
|
Cells, Cultured | 19 | 2020 | 19017 | 0.410 |
Why?
|
Glycolysis | 1 | 2016 | 837 | 0.410 |
Why?
|
Human papillomavirus 16 | 2 | 2013 | 268 | 0.400 |
Why?
|
E2F Transcription Factors | 13 | 2021 | 270 | 0.400 |
Why?
|
Humans | 150 | 2024 | 767991 | 0.400 |
Why?
|
Oncogene Proteins v-myb | 1 | 2012 | 26 | 0.400 |
Why?
|
G1 Phase | 8 | 2022 | 403 | 0.390 |
Why?
|
cdc25 Phosphatases | 2 | 2004 | 60 | 0.390 |
Why?
|
Animals | 75 | 2024 | 169222 | 0.390 |
Why?
|
Immunoblotting | 5 | 2020 | 1647 | 0.390 |
Why?
|
CREB-Binding Protein | 6 | 2006 | 147 | 0.390 |
Why?
|
Arabidopsis | 1 | 2015 | 466 | 0.390 |
Why?
|
Benzamides | 2 | 2014 | 1377 | 0.380 |
Why?
|
Growth Substances | 3 | 2013 | 759 | 0.380 |
Why?
|
Proto-Oncogene Proteins | 8 | 2018 | 4525 | 0.380 |
Why?
|
Protein Structure, Tertiary | 12 | 2012 | 3771 | 0.370 |
Why?
|
Phosphoprotein Phosphatases | 4 | 2020 | 327 | 0.360 |
Why?
|
Molecular Sequence Data | 33 | 2014 | 17617 | 0.360 |
Why?
|
Viruses | 3 | 2023 | 373 | 0.360 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2022 | 2428 | 0.350 |
Why?
|
Mutation | 23 | 2023 | 30211 | 0.350 |
Why?
|
Receptors, Virus | 2 | 2012 | 652 | 0.350 |
Why?
|
Transfection | 21 | 2019 | 5757 | 0.350 |
Why?
|
Pyridines | 2 | 2022 | 2893 | 0.340 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2019 | 2204 | 0.340 |
Why?
|
Genes, Retinoblastoma | 6 | 2009 | 125 | 0.340 |
Why?
|
Adenoviridae | 4 | 2012 | 1092 | 0.340 |
Why?
|
Retinoblastoma Binding Proteins | 3 | 2021 | 101 | 0.330 |
Why?
|
Virus Integration | 3 | 2021 | 307 | 0.320 |
Why?
|
Cyclin E | 5 | 2016 | 155 | 0.310 |
Why?
|
Cyclin-Dependent Kinases | 7 | 2022 | 661 | 0.310 |
Why?
|
Immunization | 3 | 2021 | 1218 | 0.300 |
Why?
|
Retinoblastoma | 6 | 2009 | 321 | 0.300 |
Why?
|
Cell Line, Tumor | 16 | 2020 | 17128 | 0.300 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2023 | 2889 | 0.300 |
Why?
|
Schizosaccharomyces | 4 | 2013 | 236 | 0.300 |
Why?
|
DNA Damage | 5 | 2020 | 2470 | 0.290 |
Why?
|
Crk-Associated Substrate Protein | 1 | 2007 | 39 | 0.290 |
Why?
|
Transcription Factor DP1 | 11 | 2011 | 136 | 0.290 |
Why?
|
HeLa Cells | 9 | 2016 | 3074 | 0.290 |
Why?
|
Poliovirus Vaccines | 1 | 2006 | 13 | 0.270 |
Why?
|
Mice | 45 | 2024 | 82024 | 0.270 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2020 | 2906 | 0.270 |
Why?
|
Amino Acid Sequence | 27 | 2014 | 13420 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4050 | 0.270 |
Why?
|
Piperazines | 2 | 2014 | 2552 | 0.270 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 957 | 0.270 |
Why?
|
Tyrosine 3-Monooxygenase | 3 | 2004 | 367 | 0.270 |
Why?
|
Virus Replication | 4 | 2018 | 2458 | 0.270 |
Why?
|
Fibroblasts | 12 | 2021 | 4176 | 0.260 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13658 | 0.260 |
Why?
|
Cell Division | 18 | 2005 | 4473 | 0.260 |
Why?
|
Genes, cdc | 2 | 2019 | 113 | 0.260 |
Why?
|
NIH 3T3 Cells | 5 | 2011 | 668 | 0.260 |
Why?
|
Fetal Growth Retardation | 2 | 2007 | 592 | 0.260 |
Why?
|
Pyrimidines | 3 | 2019 | 3046 | 0.260 |
Why?
|
DNA Topoisomerase IV | 1 | 2005 | 42 | 0.250 |
Why?
|
Down-Regulation | 4 | 2019 | 2936 | 0.250 |
Why?
|
Binding Sites | 21 | 2012 | 6022 | 0.250 |
Why?
|
Drug Contamination | 1 | 2006 | 151 | 0.240 |
Why?
|
Fluoroquinolones | 1 | 2007 | 309 | 0.240 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2005 | 174 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2024 | 82 | 0.230 |
Why?
|
Eye Neoplasms | 4 | 1990 | 306 | 0.230 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.220 |
Why?
|
Transcription Factor TFIID | 1 | 2004 | 150 | 0.220 |
Why?
|
Cell Nucleus | 8 | 2018 | 2881 | 0.220 |
Why?
|
Mammals | 3 | 2022 | 1136 | 0.220 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2004 | 103 | 0.220 |
Why?
|
Pandemics | 4 | 2023 | 8748 | 0.220 |
Why?
|
Promoter Regions, Genetic | 9 | 2016 | 5798 | 0.220 |
Why?
|
Antibodies, Monoclonal | 10 | 2021 | 9252 | 0.210 |
Why?
|
Genes, Tumor Suppressor | 7 | 2012 | 1059 | 0.210 |
Why?
|
Virology | 1 | 2023 | 76 | 0.210 |
Why?
|
Growth Disorders | 1 | 2007 | 635 | 0.210 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2004 | 414 | 0.200 |
Why?
|
Endopeptidases | 2 | 2003 | 763 | 0.200 |
Why?
|
Cyclohexylamines | 1 | 2022 | 21 | 0.200 |
Why?
|
Gene Deletion | 5 | 2019 | 2673 | 0.200 |
Why?
|
Collodion | 2 | 2019 | 34 | 0.200 |
Why?
|
Virus Diseases | 2 | 2023 | 723 | 0.200 |
Why?
|
Dendritic Cells | 3 | 2024 | 2745 | 0.200 |
Why?
|
Neoplasms | 8 | 2023 | 22365 | 0.200 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5394 | 0.200 |
Why?
|
Precipitin Tests | 10 | 2005 | 816 | 0.200 |
Why?
|
DNA Viruses | 1 | 2021 | 33 | 0.200 |
Why?
|
Insulinoma | 1 | 2022 | 121 | 0.190 |
Why?
|
Retinoblastoma-Binding Protein 1 | 10 | 2000 | 138 | 0.190 |
Why?
|
Adenovirus E1A Proteins | 5 | 2009 | 81 | 0.190 |
Why?
|
Cytoplasm | 3 | 2002 | 1505 | 0.190 |
Why?
|
RNA, Small Interfering | 7 | 2019 | 3428 | 0.190 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2043 | 0.190 |
Why?
|
HIV-1 | 1 | 2019 | 6960 | 0.180 |
Why?
|
Tumor Cells, Cultured | 20 | 2019 | 6119 | 0.180 |
Why?
|
HSP70 Heat-Shock Proteins | 3 | 1999 | 394 | 0.180 |
Why?
|
Gene Expression Regulation, Fungal | 3 | 2013 | 497 | 0.180 |
Why?
|
Protein Kinases | 1 | 2008 | 1610 | 0.180 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2021 | 378 | 0.180 |
Why?
|
Pyrrolidines | 1 | 2022 | 340 | 0.170 |
Why?
|
Oncogene Proteins, Viral | 6 | 2014 | 342 | 0.170 |
Why?
|
Tromethamine | 1 | 2020 | 31 | 0.170 |
Why?
|
Embryonic Development | 1 | 2005 | 724 | 0.170 |
Why?
|
Heat-Shock Proteins | 5 | 1998 | 797 | 0.170 |
Why?
|
Genomic Instability | 2 | 2021 | 716 | 0.170 |
Why?
|
Enzyme Inhibitors | 4 | 2007 | 3726 | 0.170 |
Why?
|
Histone Acetyltransferases | 4 | 2014 | 335 | 0.170 |
Why?
|
Antibody Affinity | 1 | 2020 | 252 | 0.170 |
Why?
|
Meiosis | 2 | 2001 | 326 | 0.170 |
Why?
|
Interphase | 3 | 1999 | 226 | 0.170 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3669 | 0.170 |
Why?
|
Growth Inhibitors | 2 | 1998 | 375 | 0.170 |
Why?
|
Signal Transduction | 17 | 2022 | 23642 | 0.160 |
Why?
|
Recombinant Fusion Proteins | 11 | 2004 | 3740 | 0.160 |
Why?
|
Gene Expression Profiling | 5 | 2017 | 9536 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 2 | 3 | 2016 | 185 | 0.160 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1896 | 0.150 |
Why?
|
Amino Acid Motifs | 4 | 2013 | 930 | 0.150 |
Why?
|
Acetylation | 3 | 2006 | 1055 | 0.150 |
Why?
|
Embryo, Mammalian | 6 | 2014 | 1676 | 0.150 |
Why?
|
Fungal Proteins | 3 | 2001 | 906 | 0.150 |
Why?
|
Feedback, Physiological | 2 | 2016 | 482 | 0.150 |
Why?
|
Base Sequence | 18 | 2011 | 12418 | 0.150 |
Why?
|
Suppression, Genetic | 2 | 2007 | 190 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2024 | 2061 | 0.150 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2007 | 2748 | 0.150 |
Why?
|
Saccharomyces cerevisiae Proteins | 3 | 2001 | 1838 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 210 | 0.150 |
Why?
|
Survival Analysis | 5 | 2020 | 10098 | 0.150 |
Why?
|
Polyvinyls | 1 | 2018 | 154 | 0.140 |
Why?
|
Blood Vessels | 1 | 2003 | 1110 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.140 |
Why?
|
Mucin-1 | 1 | 2022 | 537 | 0.140 |
Why?
|
G2 Phase | 2 | 2014 | 134 | 0.140 |
Why?
|
RNA Splicing | 1 | 2022 | 905 | 0.140 |
Why?
|
Apoptosis | 9 | 2020 | 9521 | 0.140 |
Why?
|
Transferases | 2 | 2007 | 71 | 0.140 |
Why?
|
Gene Expression | 4 | 2022 | 7597 | 0.140 |
Why?
|
Antiviral Agents | 2 | 2023 | 3073 | 0.140 |
Why?
|
E2F1 Transcription Factor | 3 | 2015 | 182 | 0.140 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13499 | 0.130 |
Why?
|
Oncogene Proteins | 4 | 2016 | 717 | 0.130 |
Why?
|
Phylogeny | 4 | 2020 | 2843 | 0.130 |
Why?
|
Mice, Knockout | 7 | 2019 | 14486 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2018 | 435 | 0.130 |
Why?
|
Genomics | 3 | 2021 | 5925 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 2 | 2014 | 69 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.130 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1742 | 0.120 |
Why?
|
Paraganglioma, Extra-Adrenal | 2 | 2012 | 47 | 0.120 |
Why?
|
Cell Line, Transformed | 4 | 2008 | 866 | 0.120 |
Why?
|
HEK293 Cells | 5 | 2020 | 4289 | 0.120 |
Why?
|
Oncogenes | 2 | 2012 | 1232 | 0.120 |
Why?
|
Insulin-Secreting Cells | 1 | 2022 | 899 | 0.120 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1014 | 0.120 |
Why?
|
Glomus Tumor | 2 | 2012 | 62 | 0.120 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59598 | 0.120 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2005 | 88 | 0.120 |
Why?
|
Homeodomain Proteins | 2 | 2022 | 2429 | 0.120 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 22381 | 0.120 |
Why?
|
Protein Phosphatase 2 | 2 | 2014 | 231 | 0.110 |
Why?
|
Research | 1 | 2023 | 1979 | 0.110 |
Why?
|
Culture Techniques | 1 | 1995 | 530 | 0.110 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2014 | 109 | 0.110 |
Why?
|
Sequence Deletion | 4 | 2006 | 1494 | 0.110 |
Why?
|
Papilloma | 1 | 2015 | 143 | 0.110 |
Why?
|
Indoles | 1 | 2022 | 1835 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 6 | 2020 | 1966 | 0.110 |
Why?
|
Animals, Newborn | 4 | 2014 | 2678 | 0.110 |
Why?
|
RNA Interference | 4 | 2019 | 2830 | 0.110 |
Why?
|
Neoplasm Proteins | 6 | 2009 | 3601 | 0.110 |
Why?
|
Bacterial Capsules | 1 | 2015 | 247 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 616 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1230 | 0.110 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5446 | 0.110 |
Why?
|
Genome, Human | 2 | 2020 | 4443 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2019 | 1642 | 0.110 |
Why?
|
Seroepidemiologic Studies | 1 | 2014 | 404 | 0.110 |
Why?
|
Phenotype | 4 | 2019 | 16723 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2017 | 7612 | 0.100 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
Breast | 1 | 2021 | 1976 | 0.100 |
Why?
|
Viral Tropism | 1 | 2013 | 102 | 0.100 |
Why?
|
Protein Subunits | 3 | 2014 | 943 | 0.100 |
Why?
|
Cyclin B2 | 1 | 2011 | 5 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2000 | 706 | 0.100 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2012 | 97 | 0.100 |
Why?
|
CDC2-CDC28 Kinases | 2 | 2003 | 111 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 1663 | 0.100 |
Why?
|
Macromolecular Substances | 3 | 2004 | 1435 | 0.100 |
Why?
|
Structure-Activity Relationship | 3 | 2012 | 3055 | 0.100 |
Why?
|
Male | 17 | 2021 | 364641 | 0.100 |
Why?
|
Retinoblastoma-Binding Protein 4 | 1 | 2011 | 12 | 0.100 |
Why?
|
HCT116 Cells | 2 | 2016 | 404 | 0.090 |
Why?
|
3T3 Cells | 7 | 1999 | 1084 | 0.090 |
Why?
|
Hybridomas | 2 | 2021 | 443 | 0.090 |
Why?
|
Female | 20 | 2021 | 397113 | 0.090 |
Why?
|
Nuclear Localization Signals | 2 | 2002 | 78 | 0.090 |
Why?
|
Cyclin B | 2 | 2001 | 104 | 0.090 |
Why?
|
Lysine | 2 | 2006 | 1000 | 0.090 |
Why?
|
HSP40 Heat-Shock Proteins | 4 | 1998 | 85 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 369 | 0.090 |
Why?
|
Aged | 10 | 2021 | 171446 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1621 | 0.090 |
Why?
|
Primates | 1 | 2013 | 520 | 0.090 |
Why?
|
Computational Biology | 3 | 2020 | 3568 | 0.090 |
Why?
|
Dimerization | 2 | 2005 | 887 | 0.090 |
Why?
|
Epithelium | 1 | 2015 | 1607 | 0.090 |
Why?
|
Simplexvirus | 1 | 2013 | 805 | 0.080 |
Why?
|
Capsid Proteins | 2 | 2006 | 468 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2456 | 0.080 |
Why?
|
Plakophilins | 1 | 2008 | 32 | 0.080 |
Why?
|
Molecular Targeted Therapy | 3 | 2016 | 2824 | 0.080 |
Why?
|
Chondrocytes | 1 | 2014 | 800 | 0.080 |
Why?
|
Immunotherapy | 3 | 2020 | 4748 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4564 | 0.080 |
Why?
|
Ligases | 2 | 2003 | 333 | 0.080 |
Why?
|
Cell Differentiation | 4 | 2024 | 11665 | 0.080 |
Why?
|
Genes, Regulator | 1 | 1989 | 373 | 0.080 |
Why?
|
14-3-3 Proteins | 3 | 2004 | 221 | 0.080 |
Why?
|
Antibodies, Viral | 2 | 2012 | 3216 | 0.080 |
Why?
|
Viral Proteins | 2 | 2012 | 1802 | 0.080 |
Why?
|
Middle Aged | 9 | 2021 | 223422 | 0.080 |
Why?
|
Plasmids | 4 | 2014 | 2269 | 0.080 |
Why?
|
Gene Dosage | 1 | 2012 | 1211 | 0.070 |
Why?
|
Enzyme Activation | 4 | 2016 | 3587 | 0.070 |
Why?
|
Conserved Sequence | 2 | 2011 | 1162 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1907 | 0.070 |
Why?
|
Placenta | 3 | 2007 | 1725 | 0.070 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2008 | 85 | 0.070 |
Why?
|
Ribonucleotides | 1 | 2008 | 114 | 0.070 |
Why?
|
ral GTP-Binding Proteins | 1 | 2007 | 9 | 0.070 |
Why?
|
Immediate-Early Proteins | 1 | 2010 | 444 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2012 | 618 | 0.070 |
Why?
|
DNA Primers | 3 | 1997 | 2827 | 0.070 |
Why?
|
Multigene Family | 2 | 2004 | 1081 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1753 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11101 | 0.070 |
Why?
|
Genetic Complementation Test | 2 | 2006 | 557 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2013 | 616 | 0.070 |
Why?
|
Genes, p16 | 2 | 1997 | 158 | 0.070 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2017 | 858 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1674 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1505 | 0.070 |
Why?
|
Biological Evolution | 1 | 2013 | 1076 | 0.070 |
Why?
|
Mutagenesis | 4 | 2012 | 1228 | 0.070 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2007 | 152 | 0.070 |
Why?
|
Ofloxacin | 1 | 2007 | 66 | 0.070 |
Why?
|
B-Lymphocytes | 3 | 2019 | 4791 | 0.070 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2006 | 24 | 0.070 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2006 | 24 | 0.070 |
Why?
|
Disease | 1 | 2012 | 675 | 0.070 |
Why?
|
Retinal Neoplasms | 1 | 2009 | 151 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3589 | 0.070 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 492 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5314 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.070 |
Why?
|
Glutathione Transferase | 4 | 2003 | 565 | 0.070 |
Why?
|
Adult | 10 | 2022 | 223583 | 0.070 |
Why?
|
Sequence Homology | 1 | 2006 | 197 | 0.070 |
Why?
|
Transcriptional Activation | 6 | 2011 | 1752 | 0.060 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2013 | 425 | 0.060 |
Why?
|
T-Lymphocytes | 6 | 1997 | 10264 | 0.060 |
Why?
|
Genotype | 3 | 2020 | 13042 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3537 | 0.060 |
Why?
|
Subcellular Fractions | 3 | 2003 | 526 | 0.060 |
Why?
|
Cell Hypoxia | 1 | 2008 | 662 | 0.060 |
Why?
|
Okadaic Acid | 2 | 2003 | 67 | 0.060 |
Why?
|
Cricetinae | 3 | 2004 | 2423 | 0.060 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2018 | 451 | 0.060 |
Why?
|
Antibodies, Phospho-Specific | 1 | 2004 | 15 | 0.060 |
Why?
|
DNA Mutational Analysis | 2 | 2012 | 4114 | 0.060 |
Why?
|
COS Cells | 2 | 2004 | 1135 | 0.060 |
Why?
|
Naphthyridines | 1 | 2007 | 185 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2007 | 313 | 0.060 |
Why?
|
Cell Compartmentation | 3 | 2002 | 383 | 0.060 |
Why?
|
Models, Biological | 4 | 2012 | 9493 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2004 | 1319 | 0.060 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4785 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2019 | 1752 | 0.050 |
Why?
|
Maltose-Binding Proteins | 1 | 2003 | 62 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 1999 | 1244 | 0.050 |
Why?
|
DNA, Fungal | 2 | 2013 | 275 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11873 | 0.050 |
Why?
|
Cell-Free System | 1 | 2003 | 339 | 0.050 |
Why?
|
Anaphase | 1 | 2003 | 112 | 0.050 |
Why?
|
Aminopeptidases | 1 | 2003 | 114 | 0.050 |
Why?
|
Multiple Myeloma | 5 | 1999 | 5196 | 0.050 |
Why?
|
Proteomics | 1 | 2016 | 3912 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2004 | 1715 | 0.050 |
Why?
|
Merkel Cells | 1 | 2022 | 24 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6071 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10757 | 0.050 |
Why?
|
Cloning, Molecular | 7 | 2004 | 4168 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2008 | 3096 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2013 | 5902 | 0.050 |
Why?
|
Vidarabine | 1 | 2003 | 337 | 0.050 |
Why?
|
CDC2 Protein Kinase | 2 | 2013 | 212 | 0.050 |
Why?
|
Genes, p53 | 1 | 2004 | 711 | 0.050 |
Why?
|
Tretinoin | 1 | 2024 | 524 | 0.050 |
Why?
|
Biological Transport, Active | 1 | 2002 | 323 | 0.050 |
Why?
|
Adolescent | 4 | 2021 | 89155 | 0.050 |
Why?
|
Azepines | 1 | 2003 | 329 | 0.050 |
Why?
|
Cyclin A | 1 | 2001 | 59 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 2 | 2012 | 197 | 0.050 |
Why?
|
Telomerase | 2 | 2003 | 751 | 0.050 |
Why?
|
Microinjections | 1 | 2002 | 319 | 0.050 |
Why?
|
Microscopy, Fluorescence | 2 | 2006 | 2634 | 0.050 |
Why?
|
Contact Inhibition | 1 | 2000 | 46 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2003 | 1065 | 0.050 |
Why?
|
Gamma Rays | 2 | 2019 | 319 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1538 | 0.050 |
Why?
|
Culture Media, Serum-Free | 1 | 2000 | 148 | 0.040 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2000 | 84 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4576 | 0.040 |
Why?
|
Serine | 1 | 2004 | 831 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11068 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2002 | 1526 | 0.040 |
Why?
|
Caspases | 1 | 2003 | 882 | 0.040 |
Why?
|
Gene Targeting | 1 | 2003 | 841 | 0.040 |
Why?
|
Freeze Drying | 1 | 2019 | 97 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1972 | 0.040 |
Why?
|
DNA, Complementary | 3 | 2003 | 1989 | 0.040 |
Why?
|
Temperature | 2 | 2004 | 2234 | 0.040 |
Why?
|
Mimosine | 1 | 1999 | 7 | 0.040 |
Why?
|
Cell Survival | 2 | 2008 | 5772 | 0.040 |
Why?
|
Kenya | 1 | 2022 | 757 | 0.040 |
Why?
|
Proteome | 2 | 2007 | 1890 | 0.040 |
Why?
|
Disease Susceptibility | 4 | 1990 | 1793 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9412 | 0.040 |
Why?
|
Cyclin B1 | 1 | 1999 | 57 | 0.040 |
Why?
|
Calcineurin | 1 | 2000 | 235 | 0.040 |
Why?
|
Child | 2 | 2020 | 80906 | 0.040 |
Why?
|
Cell Count | 2 | 2000 | 1831 | 0.040 |
Why?
|
Policy Making | 1 | 2023 | 546 | 0.040 |
Why?
|
Electricity | 1 | 2019 | 175 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1151 | 0.040 |
Why?
|
Histone Deacetylases | 2 | 2002 | 717 | 0.040 |
Why?
|
N-Acetylneuraminic Acid | 1 | 1999 | 175 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26420 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2020 | 238 | 0.040 |
Why?
|
DNA | 6 | 2003 | 7213 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3834 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 1999 | 157 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12252 | 0.040 |
Why?
|
Crystallography, X-Ray | 3 | 2012 | 1951 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 369 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2007 | 1726 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4904 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2007 | 1472 | 0.040 |
Why?
|
Epigenomics | 1 | 2023 | 959 | 0.040 |
Why?
|
Leukemia, Plasma Cell | 1 | 1997 | 46 | 0.040 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 1997 | 48 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 861 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 1999 | 273 | 0.040 |
Why?
|
Telomere | 1 | 2003 | 943 | 0.030 |
Why?
|
Interleukin-6 | 2 | 1997 | 3228 | 0.030 |
Why?
|
Epitopes | 2 | 2021 | 2526 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2009 | 6371 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2012 | 464 | 0.030 |
Why?
|
Capsid | 1 | 1999 | 435 | 0.030 |
Why?
|
Time Factors | 4 | 2016 | 40214 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2006 | 12797 | 0.030 |
Why?
|
Herpesvirus 4, Human | 2 | 2012 | 1082 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1608 | 0.030 |
Why?
|
Models, Chemical | 2 | 2012 | 610 | 0.030 |
Why?
|
Genes, Fungal | 1 | 1997 | 440 | 0.030 |
Why?
|
Protein Transport | 1 | 2002 | 1951 | 0.030 |
Why?
|
Zea mays | 1 | 1996 | 109 | 0.030 |
Why?
|
Interleukin-7 | 1 | 1996 | 146 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 1996 | 1996 | 0.030 |
Why?
|
Lentivirus | 1 | 2019 | 518 | 0.030 |
Why?
|
Molecular Weight | 2 | 1996 | 2173 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2149 | 0.030 |
Why?
|
Zinc Fingers | 1 | 1998 | 577 | 0.030 |
Why?
|
Genes, Immunoglobulin | 1 | 1996 | 283 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1997 | 1560 | 0.030 |
Why?
|
Spermatogenesis | 1 | 2016 | 260 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1144 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1788 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1605 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2000 | 1074 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 542 | 0.030 |
Why?
|
Prognosis | 2 | 2020 | 29979 | 0.030 |
Why?
|
Models, Genetic | 3 | 2002 | 3447 | 0.030 |
Why?
|
Harmine | 1 | 2014 | 10 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 230 | 0.030 |
Why?
|
Information Dissemination | 1 | 2023 | 1142 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 800 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 664 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6231 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1996 | 647 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1104 | 0.030 |
Why?
|
Pregnancy | 2 | 2007 | 30260 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1405 | 0.030 |
Why?
|
Testis | 1 | 2016 | 783 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 54924 | 0.030 |
Why?
|
Osteosarcoma | 1 | 1999 | 911 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2016 | 353 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1997 | 2178 | 0.030 |
Why?
|
Chromatin | 2 | 2021 | 2981 | 0.030 |
Why?
|
Adenine | 1 | 2019 | 995 | 0.030 |
Why?
|
Molecular Structure | 1 | 1997 | 1883 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15442 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 60048 | 0.030 |
Why?
|
Ethers, Cyclic | 1 | 1992 | 32 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12795 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13665 | 0.030 |
Why?
|
Infant | 1 | 2014 | 36534 | 0.020 |
Why?
|
Hydroxyurea | 2 | 1993 | 284 | 0.020 |
Why?
|
HIV Infections | 1 | 2019 | 17569 | 0.020 |
Why?
|
Drug Synergism | 1 | 2016 | 1760 | 0.020 |
Why?
|
Peptide Mapping | 1 | 1992 | 260 | 0.020 |
Why?
|
Rats | 4 | 2000 | 23751 | 0.020 |
Why?
|
ras Proteins | 1 | 1997 | 1054 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2014 | 328 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 42665 | 0.020 |
Why?
|
Genetic Vectors | 2 | 2019 | 3402 | 0.020 |
Why?
|
Plasminogen Inactivators | 1 | 1991 | 37 | 0.020 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 170 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2216 | 0.020 |
Why?
|
E1A-Associated p300 Protein | 3 | 1997 | 125 | 0.020 |
Why?
|
Recombinant Proteins | 3 | 1996 | 6515 | 0.020 |
Why?
|
Haplorhini | 2 | 1989 | 523 | 0.020 |
Why?
|
Blast Crisis | 1 | 1991 | 102 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2003 | 317 | 0.020 |
Why?
|
Papillomaviridae | 2 | 2012 | 1140 | 0.020 |
Why?
|
Cyclin D2 | 2 | 2003 | 97 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1996 | 1390 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3437 | 0.020 |
Why?
|
Cell Death | 2 | 2013 | 1679 | 0.020 |
Why?
|
Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1991 | 642 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 1997 | 1058 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1667 | 0.020 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1991 | 283 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6517 | 0.020 |
Why?
|
Jurkat Cells | 2 | 2002 | 740 | 0.020 |
Why?
|
Leucovorin | 1 | 1991 | 643 | 0.020 |
Why?
|
Fanconi Anemia | 1 | 2012 | 327 | 0.020 |
Why?
|
Cyclin D1 | 3 | 1997 | 453 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2050 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1996 | 705 | 0.020 |
Why?
|
Stromal Cells | 2 | 2009 | 1336 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 65364 | 0.020 |
Why?
|
von Hippel-Lindau Disease | 2 | 2004 | 154 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2040 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3437 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 663 | 0.020 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2004 | 304 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20218 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2003 | 283 | 0.020 |
Why?
|
Protein Folding | 1 | 2012 | 871 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1750 | 0.020 |
Why?
|
Tibia | 1 | 2014 | 1076 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1993 | 1104 | 0.020 |
Why?
|
Incidence | 1 | 2006 | 21532 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 751 | 0.020 |
Why?
|
Models, Animal | 1 | 2014 | 2120 | 0.020 |
Why?
|
Protein Conformation | 1 | 1995 | 3956 | 0.020 |
Why?
|
Fetus | 1 | 1995 | 1884 | 0.020 |
Why?
|
Fibronectins | 1 | 1991 | 722 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2004 | 1550 | 0.020 |
Why?
|
Osteogenesis | 1 | 2014 | 1288 | 0.020 |
Why?
|
Fluorouracil | 1 | 1991 | 1652 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2600 | 0.020 |
Why?
|
Lymphocytes | 3 | 2002 | 2614 | 0.020 |
Why?
|
Adenovirus Early Proteins | 3 | 1991 | 58 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11221 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10590 | 0.020 |
Why?
|
Glioblastoma | 1 | 2000 | 3463 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 1997 | 5505 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12828 | 0.020 |
Why?
|
Immunoassay | 1 | 1988 | 746 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14718 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 2 | 1997 | 462 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18062 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1991 | 4857 | 0.010 |
Why?
|
Radioligand Assay | 1 | 2004 | 366 | 0.010 |
Why?
|
Cobalt | 1 | 2003 | 148 | 0.010 |
Why?
|
Cyclohexanes | 1 | 2003 | 151 | 0.010 |
Why?
|
Models, Molecular | 2 | 2003 | 5402 | 0.010 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 57 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 1991 | 1739 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2004 | 192 | 0.010 |
Why?
|
Epithelial Cells | 2 | 2009 | 3703 | 0.010 |
Why?
|
Sesquiterpenes | 1 | 2003 | 175 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3798 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 284 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3620 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 610 | 0.010 |
Why?
|
Protein Structure, Quaternary | 1 | 2003 | 426 | 0.010 |
Why?
|
Chromosome Segregation | 1 | 2003 | 230 | 0.010 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 505 | 0.010 |
Why?
|
Centrosome | 1 | 2003 | 210 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81746 | 0.010 |
Why?
|
Karyopherins | 1 | 2002 | 134 | 0.010 |
Why?
|
Kinetics | 2 | 2003 | 6328 | 0.010 |
Why?
|
Skin | 1 | 1995 | 4503 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5335 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 610 | 0.010 |
Why?
|
Retroviridae | 1 | 2003 | 846 | 0.010 |
Why?
|
Histone Chaperones | 1 | 2001 | 82 | 0.010 |
Why?
|
Lung | 3 | 1995 | 10094 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2002 | 393 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2002 | 433 | 0.010 |
Why?
|
Leucine | 1 | 2002 | 547 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 542 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 16041 | 0.010 |
Why?
|
Threonine | 1 | 2001 | 273 | 0.010 |
Why?
|
Peptides | 2 | 2003 | 4354 | 0.010 |
Why?
|
Cyclosporine | 1 | 2002 | 777 | 0.010 |
Why?
|
Monocytes | 1 | 1989 | 2605 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 627 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 1999 | 104 | 0.010 |
Why?
|
Acetyltransferases | 1 | 2000 | 231 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 1999 | 42 | 0.010 |
Why?
|
Ubiquitins | 1 | 2000 | 366 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2002 | 9556 | 0.010 |
Why?
|
Tacrolimus | 1 | 2002 | 750 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 624 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 1999 | 316 | 0.010 |
Why?
|
United States | 1 | 2006 | 73027 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2000 | 414 | 0.010 |
Why?
|
Genes, Wilms Tumor | 1 | 1998 | 92 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1990 | 3409 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41749 | 0.010 |
Why?
|
Wound Healing | 1 | 2008 | 2808 | 0.010 |
Why?
|
WT1 Proteins | 1 | 1998 | 183 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1989 | 4427 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 440 | 0.010 |
Why?
|
Mitogens | 1 | 1997 | 229 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2003 | 2004 | 0.010 |
Why?
|
Mitotic Index | 1 | 1996 | 160 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1996 | 76 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2393 | 0.010 |
Why?
|
Cerebellum | 1 | 2004 | 1522 | 0.010 |
Why?
|
Ploidies | 1 | 1996 | 287 | 0.010 |
Why?
|
Seeds | 1 | 1996 | 124 | 0.010 |
Why?
|
Chromosome Mapping | 2 | 1994 | 4618 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6894 | 0.010 |
Why?
|
Glycoproteins | 1 | 2003 | 2201 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1997 | 474 | 0.010 |
Why?
|
Kidney Glomerulus | 1 | 1998 | 571 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1991 | 3626 | 0.010 |
Why?
|
Virulence | 1 | 1999 | 1297 | 0.010 |
Why?
|
Cell Separation | 1 | 2001 | 1729 | 0.010 |
Why?
|
Adenovirus E2 Proteins | 1 | 1994 | 8 | 0.010 |
Why?
|
E2F2 Transcription Factor | 1 | 1994 | 35 | 0.010 |
Why?
|
E2F3 Transcription Factor | 1 | 1994 | 36 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1743 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 1999 | 1160 | 0.010 |
Why?
|
Genes, Suppressor | 1 | 1993 | 47 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2001 | 2202 | 0.010 |
Why?
|
Gene Library | 1 | 1996 | 1065 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1999 | 1189 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2055 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1994 | 341 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1994 | 348 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 1683 | 0.010 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 1992 | 35 | 0.010 |
Why?
|
Deferoxamine | 1 | 1993 | 155 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1997 | 1207 | 0.010 |
Why?
|
Nocodazole | 1 | 1992 | 95 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1992 | 298 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1992 | 205 | 0.010 |
Why?
|
Phosphotransferases | 1 | 1993 | 302 | 0.010 |
Why?
|
Estrogens | 1 | 1999 | 1536 | 0.010 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1992 | 133 | 0.010 |
Why?
|
Mink | 1 | 1991 | 31 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1992 | 1142 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 775 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1854 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 1999 | 2253 | 0.010 |
Why?
|
Thrombospondins | 1 | 1991 | 196 | 0.010 |
Why?
|
Point Mutation | 1 | 1995 | 1594 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1991 | 287 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2001 | 2680 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 1997 | 1667 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1991 | 525 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1996 | 21206 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 1992 | 693 | 0.000 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1994 | 2510 | 0.000 |
Why?
|
RNA-Binding Proteins | 1 | 1997 | 1889 | 0.000 |
Why?
|
Oligonucleotides | 1 | 1991 | 563 | 0.000 |
Why?
|
Blood Proteins | 1 | 1993 | 1191 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8120 | 0.000 |
Why?
|
Bone Marrow | 1 | 1997 | 2935 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1994 | 1367 | 0.000 |
Why?
|
Germ-Line Mutation | 1 | 1995 | 1883 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1993 | 1895 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1994 | 4248 | 0.000 |
Why?
|
DNA Methylation | 1 | 1997 | 4426 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1996 | 3841 | 0.000 |
Why?
|
Kidney | 1 | 1998 | 7065 | 0.000 |
Why?
|
Carcinoma, Renal Cell | 1 | 1995 | 3187 | 0.000 |
Why?
|